Thu, May 4, 2023

Kyle Mikson Maintained (TXG) at Strong Buy with Increased Target to $65 on, May 4th, 2023

Kyle Mikson of Canaccord Genuity, Maintained "10x Genomics, Inc." (TXG) at Strong Buy with Increased Target from $58 to $65 on, May 4th, 2023.

Kyle has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Kyle's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • John Sourbeer of "UBS" Initiated at Hold and Held Target at $50 on, Thursday, February 2nd, 2023


This is the rating of the analyst that currently disagrees with Kyle


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $65 on, Thursday, February 16th, 2023